Literature DB >> 19774676

Decreased level and defective function of circulating endothelial progenitor cells in children with moyamoya disease.

Jin Hyun Kim1, Ji-Hye Jung, Ji Hoon Phi, Hyun-Seung Kang, Jeong Eun Kim, Jong Hee Chae, Sang-Jeong Kim, Young-Hoon Kim, Young Yim Kim, Byung-Kyu Cho, Kyu-Chang Wang, Seung-Ki Kim.   

Abstract

Circulating endothelial progenitor cells (EPCs) play an important role in physiological and pathological neovascularization and may be involved in attenuating ischemic diseases. This study aimed to characterize circulating EPCs in moyamoya disease (MMD), one of the most common pediatric cerebrovascular diseases. Twenty-eight children with MMD prior to any surgical treatment and 12 healthy volunteers were recruited. Peripheral blood mononuclear cells (PBMNCs) were isolated and cultured in endothelial cell growth medium. Temporal change of phenotype of cells was analyzed on days 0 and 7. The formation of EPC clusters was evaluated on day 7. The CD34(+), CD133(+), and KDR(+) cells, and the number of EPC clusters was significantly reduced in children with MMD. In controls, CD34(+) cells were significantly decreased on day 7 compared with day 0, but in MMD they were only slightly decreased. The change in KDR(+) cells on day 7 compared with day 0 was the reverse of that for CD34(+) cells. Functional assay of EPC demonstrated less tube formation and increased senescent-like phenotype in children with MMD. Analysis of the circulating EPCs of MMD children reveals decreased level and defective function. This study suggests that circulating EPCs may be associated with MMD pathogenesis. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19774676     DOI: 10.1002/jnr.22228

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  22 in total

1.  Panobinostat, a histone deacetylase inhibitor, rescues the angiogenic potential of endothelial colony-forming cells in moyamoya disease.

Authors:  Anshika Jangra; Seung Ah Choi; Eun Jung Koh; Youn Joo Moon; Kyu-Chang Wang; Ji Hoon Phi; Ji Yeoun Lee; Seung-Ki Kim
Journal:  Childs Nerv Syst       Date:  2019-02-27       Impact factor: 1.475

Review 2.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

Review 3.  Progress in moyamoya disease.

Authors:  Shuling Shang; Da Zhou; Jingyuan Ya; Sijie Li; Qi Yang; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  Neurosurg Rev       Date:  2018-06-18       Impact factor: 3.042

Review 4.  Experimental Animal Models for Moyamoya Disease: A Species-Oriented Scoping Review.

Authors:  Lei Cao; Yang Dong; Kaiwen Sun; Dongpeng Li; Hao Wang; Hongwei Li; Bo Yang
Journal:  Front Surg       Date:  2022-07-01

Review 5.  Circulating Progenitor Cells and Childhood Cardiovascular Disease.

Authors:  Eric J Kort; Lacey Croskey; Taryn Scibienski; Surender Rajasekaran; Stefan Jovinge
Journal:  Pediatr Cardiol       Date:  2015-11-11       Impact factor: 1.655

Review 6.  Pathological Circulating Factors in Moyamoya Disease.

Authors:  Yao-Ching Fang; Ling-Fei Wei; Chaur-Jong Hu; Yong-Kwang Tu
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

Review 7.  Moyamoya Biomarkers.

Authors:  Edward R Smith
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

Review 8.  Circulating Vascular Progenitor Cells in Moyamoya Disease.

Authors:  Hyun-Seung Kang; Kyu-Chang Wang; Seung-Ki Kim
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

Review 9.  The Pathophysiology of Moyamoya Disease: An Update.

Authors:  Oh Young Bang; Miki Fujimura; Seung-Ki Kim
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

Review 10.  Moyamoya Disease and Spectrums of RNF213 Vasculopathy.

Authors:  Oh Young Bang; Jong-Won Chung; Dong Hee Kim; Hong-Hee Won; Je Young Yeon; Chang-Seok Ki; Hyung Jin Shin; Jong-Soo Kim; Seung Chyul Hong; Duk-Kyung Kim; Akio Koizumi
Journal:  Transl Stroke Res       Date:  2019-10-24       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.